Page last updated: 2024-12-06

perphenazine decanoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID62873
CHEBI ID177469
MeSH IDM0136785

Synonyms (15)

Synonym
CHEBI:177469
2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl decanoate
perphenazine decanoate
61120-81-8
D08341
trilafon dekanoat (tn)
einecs 262-615-2
unii-rhe0987nhe
2-(4-(3-(2-chloro-10h-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl decanoate
rhe0987nhe ,
decanoic acid, 2-(4-(3-(2-chloro-10h-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester
perphenazine decanoate [who-dd]
DTXSID00210006
2-[4-[3-(2-chloro-10h-phenothiazin-10-yl)propyl]-1-piperazinyl]ethyl decanoate
Q27288121

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" This study demonstrates that PD is a safe and effective remedy for maintenance therapy in psychotic patients."( Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
Hansen, LB; Højholdt, K; Knudsen, P; Larsen, NE, 1985
)
0.53

Pharmacokinetics

ExcerptReferenceRelevance
"The purpose of the study was to investigate clinical and pharmacokinetic parameters concerning perphenazine decanoate (PD) and haloperidol decanoate (HD) with an interval of 3 weeks during a study period of 51 weeks."( A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients.
Dencker, SJ; Giös, I; Mårtensson, E; Nordén, T; Nyberg, G; Persson, R; Roman, G; Stockman, O; Svärd, KO, 1994
)
0.75

Dosage Studied

ExcerptRelevanceReference
" The dosage and intervals between injections were on an individual basis."( Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
Hansen, LB; Knudsen, P; Larsen, NE, 1985
)
1.71
" In the patients treated with PD there were signs of accumulation indicating the possibility of prolonging dosage intervals."( Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
Auken, G; Hansen, LB; Højholdt, K; Knudsen, P; Larsen, NE; Waehrens, J, 1985
)
1.71
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenothiazines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (40.00)18.7374
1990's6 (40.00)18.2507
2000's2 (13.33)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.74 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (20.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies2 (13.33%)4.05%
Observational0 (0.00%)0.25%
Other8 (53.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]